Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / February / What Cats Can Tell Us About Cancer
Oncology Liquid biopsy Omics Precision medicine Screening and monitoring Research and Innovations Molecular Pathology

What Cats Can Tell Us About Cancer

Large-scale feline sequencing study highlights diagnostic and therapeutic targets shared with human cancers

02/25/2026 News 1 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Clinical Report: What Cats Can Tell Us About Cancer

Overview

Genetic profiling of nearly 500 domestic cats with cancer has identified driver mutations that closely resemble those found in human tumors. This study highlights the potential of feline cancer as a model for advancing diagnostic and therapeutic strategies in oncology.

Background

Understanding the genetic underpinnings of cancer in animals can provide valuable insights into human disease. The study of feline cancers, particularly given their similarities to human malignancies, may enhance our understanding of cancer biology and inform treatment approaches. This research underscores the importance of comparative oncology in bridging gaps between veterinary and human medicine.

Data Highlights

FindingDetails
Sample Size493 tumor–normal tissue pairs
Feline Cancer Types13 types analyzed
Driver Genes Identified31 likely driver genes
Most Common MutationTP53
FBXW7 AlterationsFound in >50% of mammary tumors

Key Findings

  • Identification of 31 likely driver genes in feline cancers.
  • TP53 was the most frequently mutated gene across tumor types.
  • FBXW7 alterations were prevalent in feline mammary carcinoma, paralleling human breast cancer.
  • PIK3CA mutations were also common in feline mammary tumors, similar to human cases.
  • Potential for genotype-guided therapy in cats based on FBXW7 alterations.

Clinical Implications

The findings suggest that feline cancers can serve as a relevant model for studying human cancer, particularly in understanding shared genetic mutations. This research may lead to new diagnostic and therapeutic strategies that leverage insights from both species.

Conclusion

The study establishes a foundational genomic reference for feline cancers, emphasizing the relevance of comparative oncology in advancing cancer research and treatment for both humans and pets.

References

  1. Geoffrey Wood, Ontario Veterinary College, Science, 2026 -- What Cats Can Tell Us About Cancer
  2. The ASCO Post — Yet Another Reason Why Dogs Are Our Best Friends
  3. The ASCO Post — Contagious Cancer and an Unexplained Phenomenon Might Inspire Future Therapies
  4. The ASCO Post — Research Insights From the AACR Special Conference on Pancreatic Cancer
  5. the pathologist — Evaluating Dogs’ Potential Role in Cancer Screening
  6. Yet Another Reason Why Dogs Are Our Best Friends
  7. Contagious Cancer and an Unexplained Phenomenon Might Inspire Future Therapies
  8. Research Insights From the AACR Special Conference on Pancreatic Cancer
  9. Evaluating Dogs’ Potential Role in Cancer Screening
  10. ASCO Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer Guideline Summary
  11. The oncogenome of the domestic cat - PMC
  12. Whole Exome Sequencing of Feline Oral Squamous Cell Carcinoma Reveals Genomic Parallels With Human Head and Neck Squamous Cell Carcinoma - PubMed

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Light in the Darkness
Liquid biopsy
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

Biomarkers: The Bigger Picture
Liquid biopsy
Biomarkers: The Bigger Picture

April 27, 2022

1 min read

To unlock patient care, pathologists must focus on molecular pathology and ensure efficiency and effectiveness to improve testing. With this testing, patients can benefit from the best treatment to combat their disease.

Benchmarking… Liquid Biopsy
Liquid biopsy
Benchmarking… Liquid Biopsy

May 13, 2022

1 min read

A look at the last five years of publishing on liquid biopsy

Does Your Blood Know You Have Cancer?
Liquid biopsy
Does Your Blood Know You Have Cancer?

July 25, 2022

2 min read

Detection and monitoring are crucial for melanoma outcomes – could a blood test revolutionize both?

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.